Home 2019-02-20T12:13:45+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

Insightful presentation by @aledmedwards from @M4KPharma on affordable drug development
"Ymgasglu, i rannu, er daioni"

Fantastic visit to the dreaming spires of Oxford hearing from @thesgconline about @BrainTumourOrg funded work with @M4KPharma on ALK2 inhibitor for #DIPG. Positive progress towards a drug for clinic but still some work to do #ACureCantWait @OICR_news @ICR_London @CRiverLabs

For #ChildhoodCancerAwarenessMonth Elisabet Fernandez Potente, a Scientific Officer in the ICR's Glioma Team, tells us why she works on childhood cancer.


This is why we are looking at new funding models and regulatory processes to support #OpenScience and keep a lid on prices. @M4KPharma is an example of this. https://t.co/1CNJuk6Jvu

#OpenScience partnerships ought to form the heart of the public option @M4KPharma @thesgconline @TheNeuro_MNI https://t.co/9FUrei22sx

Load More...

Latest Blog Posts